What will Palatin Technologies'stock price reach in the next year?
On average, they expect Palatin Technologies' stock price to reach $3.50 in the next year. This suggests a possible upside of 790.6% from the stock's current price.
Where can I buy shares of PTN?
Shares of PTN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What does PTN stand for?
Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, today announced results for its second quarter ended December 31, 2020.
How did Palatin Technologies (PTN) perform in Q3 earnings?
Palatin Technologies, Inc. (NYSEAMERICAN:PTN) issued its quarterly earnings results on Monday, November, 15th. The biopharmaceutical company reported ($0.03) earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.03). The biopharmaceutical company had revenue of $0.16 million for the quarter.
Should I buy or sell Palatin Technologies stock right now?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Palatin Technologies in the last year. There are current...
What is Palatin Technologies' stock price forecast for 2022?
2 brokers have issued 12 month price objectives for Palatin Technologies' shares. Their forecasts range from $2.00 to $5.00. On average, they antic...
How has Palatin Technologies' stock performed in 2022?
Palatin Technologies' stock was trading at $0.43 at the start of the year. Since then, PTN stock has decreased by 24.0% and is now trading at $0.32...
Are investors shorting Palatin Technologies?
Palatin Technologies saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 2,030,000 shares,...
How were Palatin Technologies' earnings last quarter?
Palatin Technologies, Inc. (NYSEAMERICAN:PTN) issued its quarterly earnings results on Tuesday, May, 17th. The biopharmaceutical company reported (...
Who are Palatin Technologies' key executives?
Palatin Technologies' management team includes the following people: Dr. Carl Spana Ph.D. , Co-Founder, Pres, CEO & Director (Age 60, Pay $924.5...
Who are some of Palatin Technologies' key competitors?
Some companies that are related to Palatin Technologies include CytoDyn (CYDY) , Aerovate Therapeutics (AVTE) , Akero Therapeutics (AKRO) , Lia...
What other stocks do shareholders of Palatin Technologies own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Palatin Technologies investors own include (XXII) , Heat...
What is Palatin Technologies' stock symbol?
Palatin Technologies trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "PTN."
What is the PTN symbol?
What is the P/E ratio of Palatin Technologies?
Palatin Technologies trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "PTN."
Is Palatin Technologies a buy?
The P/E ratio of Palatin Technologies is -2.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Does Palatin pay dividends?
Palatin Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
